Influence of GABA derivatives on the DNA damage of placenta and fetuses’s brain at experimental preeclampsia
- Authors: Sirekanyan A.G.1, Verle O.V.1, Dudchenko G.P.1, Perfilova V.N.1, Verovskiy V.E.1, Ostrovsky O.V.1, Tyurenkov I.N.1
-
Affiliations:
- Volgograd State Medical University
- Issue: Vol 20, No 5 (2022)
- Pages: 53-58
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113812
- DOI: https://doi.org/10.29296/24999490-2022-05-07
- ID: 113812
Cite item
Abstract
Gestosis is a complication of the normal course of the gestational process that occurs during pregnancy, childbirth and in the first days of the postpartum period, characterized by a deep disorder of the functions of vital organs and systems. Preeclampsia (PE), as a form of gestosis, is an important health and social problem worldwide, remaining one of the main causes of perinatal and maternal morbidity and mortality. The aim of the study was to evaluate the effects of GABA derivatives on the genome integrity of placental cells of female rats with experimental PE and the state of DNA of brain cells of the offspring of these animals. Material and methods: the experiment was carried out on white nonlinear pregnant rats at the age of3 months weighing 210-230 g. After fertilization, pregnant females were moved to individual maintenance cells and an EP model was reproduced on them by replacing drinking water with 1.8% sodium chloride solution from the 1st to the 20h day of pregnancy. Increased blood pressure and registered proteinuria in the daily urine on the 1st and 20th days of gestation were considered to be signs of PE in pregnant female rats. The assessment of DNA damage was investigated by the DNA comet method. The results of the study showed a 3 and 2.6-fold increase in DNA in comet tails respectively. In animals treated with salifen (an adduct of phenibut and salicylic acid in a molar ratio of 2:1) at a dose of 15 mg/ kg once, intragastrically during pregnancy, the level of DNA damage in the corresponding organs was 3.0 and 1.4 times lower than in the group with EP. Phenibut (y-amino-ß-phenylbutyric acid hydrochloride) at a dose of 50 mg/kg and succicard (an adduct of phenotropil and succinic acid) at a dose of 44 mg/kg once, intragastrically, did not affect the level of genome damage in placenta and fetal brain cells.
Full Text
About the authors
Anna Gragatovna Sirekanyan
Volgograd State Medical University
Author for correspondence.
Email: annart888@yandex.ru
assistant of the department of Theoretical Biochemistry with a Course in Clinical Biochemistry Pavshikh Bortsov Sq. 1, Volgograd, 400131, Russian Federation
Olga Vladimirovna Verle
Volgograd State Medical University
Email: verle_olga@mail.ru
assistant of the department of Theoretical Biochemistry with a Course in Clinical Biochemistry Pavshikh Bortsov Sq. 1, Volgograd, 400131, Russian Federation
Galina Petrovna Dudchenko
Volgograd State Medical University
Email: dgalina@mail.ru
Professor of the department of Theoretical Biochemistry with a Course in Clinical Biochemistry; Doctor of Biological Sciences, Professor. Pavshikh Bortsov Sq. 1, Volgograd, 400131, Russian Federation
Valentina Nikolaevna Perfilova
Volgograd State Medical University
Email: vnperfilova@mail.ru
Professor of the Department of Pharmacology and Pharmacy of the NYMPH Institute; Doctor of Biological Sciences, Professor. Novorossiyskaya Sq. 39, Volgograd, 400087, Russian Federation
Valerian Evgenevich Verovskiy
Volgograd State Medical University
Email: veverovsky@gmail.com
Docent of the department of Theoretical Biochemistry with a Course in Clinical Biochemistry; Candidate of Chemical Sciences. Pavshikh Bortsov Sq. 1, Volgograd, 400131, Russian Federation
Oleg Vladimirovich Ostrovsky
Volgograd State Medical University
Email: ol.ostr@gmail.com
The Head of the chair of the department of Theoretical Biochemistry with a Course in Clinical Biochemistry; Doctor of medical sciences, Professor. Pavshikh Bortsov Sq. 1, Volgograd, 400131, Russian Federation
Ivan Nikolaevich Tyurenkov
Volgograd State Medical University
Email: fibfuv@mail.ru
The Head of the chair of the department of Pharmacology and Pharmacy of the NYMPH Institute; Doctor of medical sciences, Professor, corresponding member of RAS. Novorossiyskaya Sq. 39, Volgograd, 400087, Russian Federation
References
- Critchley H., Maclean A., Poston А., Walker J. Preeclampsia. RCOG Press. London. 2003; 189-207.
- Hutcheon, J.A., Lisonkova S., Joseph K.S. Epidemiology of preeclampsia and the other hypertensive disorders of pregnancy Int. J. Best Practice and Research Clinical Obstetrics and Gynaecology. 2011; 25 (4): 391-403. https://doi.org/10.1016/j.bpob-gyn.2011.01.006
- Макаров О.В., Ткачева О.Н, Волкова Е.В. Преэклампсия и хроническая артериальная гипертензия. Клинические аспекты. М.: ГЭОТАР-Медиа, 2010; 135
- Сидорова И.С., Кулаков М.А., Никитина Н.А, Рзаева А.А. Роль плода в развитие преэклампсии. Акушерство и гинекология. 2012; 5: 23-8.
- Rеdman C.W., Sаrgent I.L. Immunology of prееclampsia. Am. J. Reprod. Immunol. 2010; 63: 534-43. https://doi.org/10.1111/j.1600-0897.2010.00831.x
- Перфилова В.Н., Иванова Л.Б., Карамышева В.И., Бородин Д.Д. Влияние новых солей фенибута на физическое и психическое развитие потомства крыс с экспериментальным гестозом. Экспериментальная и клиническая фармакология. 2012; 75 (3): 18-20.
- Тюренков И.Н., Перфилова В.Н., Попова Т.А., Иванова Л.Б., Прокофьев И.И., Гуляева О.В., Л.И. Штепа. Изменение оксидантного и антиоксидантного статуса у самок с экспериментальным гестозом под влиянием производных ГАМК. Бюл. эксп. биол. и мед. 2013; 155 (3):340-1 https://doi.org/10.1007/s10517-013-2154-9.
- Магомедова Ш.М. Мурашко А.В. Варианты экспериментального моделирования плацентарной недостаточности и преэклампсии. Первый Московский государственный медицинский университет им. И.М. Сеченова. 2012; 6: 18-23.
- Bright J., Aylott M., Bate S. Recommendations on the statistical analysis of the Comet assay. Pharm. Stat. 2011; 10 (6): 485-93. https://doi.org/10.1002/pst.530
- Kаthlееn A. Pennington, Jessica M. Schlitt, Daniel L. Jackson, Laura C. Schulz, Danny J. Schust. Preeclampsia: multiple approaches for a multifactorial disease. Disease Models & Mechanisms. 2012; 5: 9-18. https://doi.org/10.1242/dmm.008516
- Жанатаев А. К., Дурнев А. Д., Середенин С. Б. Метод ДНК-комет в генотоксикологических исследованиях. Гигиена и санитария. 2011; 5: 86-90.
- Жанатаев А.К., Никитина В.А., Воронина Е.С., Дурнев А.Д. Методические аспекты оценки ДНК-повреждений методом «ДНК-комет». Прикладная токсикология. 2011; 2 (4): 28-37
- Онищенко Г.Г. Оценка генотоксических свойств методом ДНК-комет in-vitro. Методические рекомендации. М.: Федеральный центр гигиены и эпидемиологии Роспотребнадзора. 2010.
- Poston L., Igosheva N., Mistry H.D., Seed P.T., Shennan A.H., Rana S., Karumanchi S.A., Chappell L.C. Role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am. J. Clin. Nutr. 2011; 94 (6): 1980-5.https://doi.org/10.3945/ajcn.110.001156.
- Tadesse S., Kidane D., Guller S., Luo T., Norwitz N.G., Arcuri F., Toti P, Norwitz E.R. In vivo and in vitro evidence for placental DNA damage in preeclampsia. PLoS One. 2014; 9 (1): e86791. https://doi.org/10.1371/journal.pone.0086791.
- Зиновьева В.Н., Островский О.В. Свободнорадикальное окисление ДНК и его биомаркер окисленный гуанозин 8 oxodG. Вопросы медицинской химии. 2002; 48 (5): 419-31
- Sultana Z., Maiti K., Aitken J., Morris J., Dedman L., Smith R. Oxidative stress, placental ageing-related pathologies and adverse pregnancy outcomes. Am. J. Reprod. Immunol. 2017; 77 (5): e12653. https://doi.org/10.1111/aji.12653.
- Забродина В. В., Шредер Е. Д., Шредер О. В., Дурнев А.Д., Середенин С.Б. Влияние «Афобазола» и бетаина на ДНК-повреждения в плацентарных и эмбриональных тканях крыс с экспериментальным стрептозотоциновым диабетом. Бюл. эксп. биол. и мед. 2015; 6: 72-6. https://doi.org/10.1007/s10517-015-3068-5
- Тюренков И.Н., Воронков А.В., Слиецанс А.А., Волотова Е.В. Эндотелиопротекторы - новый класс фармакологических препаратов. Вестник РАМН. 2012; 67 (7): 50-7. https://doi.org/10.15690/vramn.v67i7.341